共 16 条
[1]
Pickar D(1995)Prospects for pharmacotherapy of schizophrenia Lancet 345 557-62
[2]
Gerlach J(1994)Drug treatment of schizophrenia: myths and realities Curr Opin Psychiatry 7 65-70
[3]
Casey DE(1996)Drug therapy: schizophrenia N Engl J Med 334 34-41
[4]
Kane JM(1996)Adverse effects of antipsychotic agents: do newer agents offer advantages? Drugs 51 895-930
[5]
Owens DGC(1988)A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia Acta Psychiatr Scand 78 49-56
[6]
McCreadie RG(1994)The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia Acta Psychiatr Scand 90 358-65
[7]
Todd N(1994)Schizophrenia N Engl J Med 330 681-90
[8]
Livingston M(1993)Subjective response to neuroleptics in schizophrenia Schizophr Bull 19 609-16
[9]
Keks N(1989)Schizophrenia, affective psychosis and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms Int Rev Neurobiol 31 297-353
[10]
McGrath J(1994)Concensus statement: the use of high dose antipsychotic medication Br J Psychiatry 164 448-58